Showing results (1671-1680 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|September 7, 2017
Crucial microRNAs and genes in metformin's anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysisYilong Li, Le Li, Guangquan Zhang, et al.Investigational New Drugs|September 15, 2017
Novel inhibitors of lysine (K)-specific Demethylase 4A with anticancer activityHyo Jeong Lee, Bo-Kyoung Kim, Kyoung Bin Yoon, et al.Investigational New Drugs|November 20, 2015
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) studyManish K Thakur, Lance K Heilbrun, Shijie Sheng, et al.Investigational New Drugs|April 1, 1989
5-Fluorouracil radiation sensitization--a brief reviewJ E ByfieldInvestigational New Drugs|April 1, 1989
Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapyP J Houghton, J A Houghton, B J Hazelton, et al.Investigational New Drugs|December 3, 2015
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with advanced solid tumorsHiroshi Nokihara, Yasuhide Yamada, Yutaka Fujiwara, et al.Investigational New Drugs|May 26, 2016
Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumorsCynthia M Nijenhuis, Edward Hellriegel, Jos H Beijnen, et al.Investigational New Drugs|May 26, 2016
The imidazoline compound RX871024 promotes insulinoma cell death independent of AMP-activated protein kinase inhibitionIrina I Zaitseva, Sergei V Zaitsev, Per-Olof BerggrenInvestigational New Drugs|June 10, 2016
Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancerSeiichiro Suzuki, Masato Karayama, Naoki Inui, et al.Investigational New Drugs|October 9, 2014
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumorsIgor Puzanov, Jeffrey Sosman, Armando Santoro, et al.Pageof 372